Merck, Moderna say melanoma vaccine meets goals in large trial - Reuters

Merck, Moderna say melanoma vaccine meets goals in large trial Reuters Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial CNBC Moderna Shares Skyrocket 85% Toward Best Day Ever—Here’s Why Forbes Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial STAT Cancer treatment could face landmark moment with promising vaccine The…